Transgenic plant and methods of stimulating spontaneous nodule formation in non-legume plants
US-2024384283-A1 · Nov 21, 2024 · US
Recombinant pokeweed antiviral proteins, compositions and methods related thereto
US9023596B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9023596-B2 |
| Application number | US-201314045437-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 3, 2013 |
| Priority date | Jul 15, 2008 |
| Publication date | May 5, 2015 |
| Grant date | May 5, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
First claim
Opening claim text (preview).
The invention claimed is: 1. A composition of matter comprising a recombinant pokeweed antiviral protein having an N-terminal cysteine. 2. A composition of claim 1 , wherein said recombinant pokeweed antiviral protein is a full length recombinant pokeweed antiviral protein. 3. A composition of claim 2 , which comprises Cys-Gly-Gly-Gly-Gly-Ser (SEQ ID NO:4) at the N-terminus of a full length recombinant pokeweed antiviral protein.…
Assignees
Inventors
Classifications
- C07K14/415Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9023596B2 cover?
- The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
- Who is the assignee on this patent?
- Cedus Inc, Univ Colorado State Res Found
- What technology area does this patent fall under?
- Primary CPC classification C07K14/415. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).